BIXINK THERAPEUTICS
BIXINK Therapeutics creates a new treatment paradigm with creativity and innovation. The company intends to become a company that becomes the source of a healthier life through the construction and convergence of technology that encompasses the times.
BIXINK THERAPEUTICS
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Font Awesome Mobile Non Scaleable Content Nginx Amazon Organization Schema Person Schema
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-12-07 | Limbix | BIXINK Therapeutics investment in Series A - Limbix | 15 M USD |
| 2020-05-05 | Limbix | BIXINK Therapeutics investment in Series A - Limbix | 9 M USD |
More informations about "BIXINK Therapeutics"
BIXINK
May 24, 2020 BIXINK, Breast cancer adjuvant treatment 'Nerlynx' has entered into Big 5 General Hospital 0 0 21 Sep 2022 ... 0 0 20 Jul 2022 Views 4197 Bixink Therapeutics signs deals to …See details»
BIXINK
DIGITAL THERAPEUTICS. OC Free ® ... BIXINK, a bio pharmaceutical company, creates a new treatment paradigm with creativity and innovation. Global drug market has been …See details»
BIXINK Therapeutics - Crunchbase Investor Profile & Investments
BIXINK Therapeutics creates a new treatment paradigm with creativity and innovation. The company intends to become a company that becomes the source of a healthier life through the …See details»
BIXINK Therapeutics investment portfolio - PitchBook
BIXINK Therapeutics's latest investment was on 07-Dec-2021 in Limbix, a company within the Healthcare Technology Systems industry. Data Transparency. Meet our data hygiene team. …See details»
MEDIA - BIXINK
Jul 20, 2022 Bixink Therapeutics signs deals to expand DTx pipelines Halimriadi Richar 24 May 2022 Views 4500 0; 12; Nerlynx in HER2-positive Early Breast Cancer, helping to overcome …See details»
Blue Note Therapeutics and Bixink Enter Licensing Agreement for …
Featured Image for Blue Note Therapeutics, Inc. SAN FRANCISCO, May 09, 2022 (GLOBE NEWSWIRE) -- Blue Note Therapeutics and Bixink Therapeutics, a bio-subsidiary of KPS, …See details»
BIXINK Therapeutics - Investments, Portfolio & Company Exits
Dec 7, 2021 BIXINK Therapeutics has had . 1. exit, which was Limbix. Which industries has this organization had the most exits in? Show . Limbix Limbix is a prescription digital therapeutics …See details»
Bixink Therapeutics - VentureRadar
Bixink Therapeutics is a biotech subsidiary of KPS Corp that focuses on building a diverse digital therapeutics (DTx) portfolio. The company has signed several DTx deals, including an …See details»
Bixink Therapeutics Co. Ltd. - CMOCRO
Bixink Therapeutics Co. Ltd. is dedicated towards establishing a new treatment paradigm via converging biotechnology and information technology. Bixink is capable of analysis, R&D, …See details»
Neratinib enters new turf | Drug Discovery News
Apr 30, 2020 Nerlynx is our top priority as we aspire to be a leading South Korean company in the field of oncology therapeutics,” added Dr. Sung Chul Kim, chief executive officer of Bixink …See details»
BIXINK Therapeutics - Updates, News, Events, Signals & Triggers
BIXINK Therapeutics creates a new treatment paradigm with creativity and innovation.See details»
BIXINK Therapeutics - CB Insights
Jul 17, 2023 Boryung and Bixink to co-market Nerlynx for HER2-positive breast cancer. Apr 4, 2024. 닫기 Boryung (formerly Boryung Pharmaceutical), a strong player in the domestic …See details»
Bixink Therapeutics and Professional Dietetics enter into …
Aug 5, 2021 Bixink Therapeutics and Professional Dietetics enter into partnership for the MUCOSAMIN® range, onco-supportive care, whereby Bixink will hold the exclusive …See details»
Bixink Therapeutics - VentureRadar
SteadyMed Therapeutics Israel Listed SteadyMed Ltd., with offices in San Ramon, CA and Rehovot, Israel, is a private, venture funded Specialty Pharmaceutical company focused on …See details»
Bixink Therapeutics - VentureRadar
Similar Companies: InStride Health USA Private InStride Health specializes in evidence-based outpatient treatment for pediatric anxiety and OCD. They offer a comprehensive approach that …See details»
BIXINK Therapeutics Stock Price, Funding, Valuation, Revenue ...
See BIXINK Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on BIXINK Therapeutics's post-money valuation and revenue.See details»
BIXINK Therapeutics - Tech Stack, Apps, Patents & Trademarks
6 days ago BIXINK Therapeutics is actively using 18 technologies for its website, according to BuiltWith. These include Viewport Meta, Euro, and Content Delivery Network. Mobile App …See details»
Bixink Therapeutics signs deals to expand DTx pipelines
May 24, 2022 What does 'Nerlynx' mean for the treatmean of HER2-positive early breast cancer? Nerlynx in HER2-positive Early Breast Cancer, helping to overcome the fear of …See details»
BIXINK
Jun 14, 2021 BIXINK may also collect certain technical information about your use of the website. This technical information may include but not limited to information about your …See details»
bixink-therapeutics.com Review - Scam Detector
Is bixink-therapeutics.com legit or a scam? Read reviews, company details, technical analysis, and more to help you decide if this site is trustworthy or fraudulent.See details»